Drug Type Small molecule drug |
Synonyms Lopressor HCT |
Target |
Action inhibitors, antagonists |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (31 Dec 1984), |
Regulation- |
Molecular FormulaC7H8ClN3O4S2 |
InChIKeyJZUFKLXOESDKRF-UHFFFAOYSA-N |
CAS Registry58-93-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | United States | 31 Dec 1984 |